This review summarizes the mechanisms of action and clinical activity of IMiDs in MM. Multiple myeloma (MM) is a malignant plasma cell disorder accounting for approximately 10% of all hematologic ...
Braunstein, MD, PhD, FACP, and hematology/oncology fellow Olivia Main, MD, talk about their choices for a patient with ...
Hosted on MSN8mon
From Cancer To Meningitis, Know How Deadly Can A Simple Rash BeMedical Mystery: Man Born With A Giant Arm Leaves Doctors Puzzled Multiple Myeloma: 7 Subtle Signs Of The Disease You Should Know About Apart from being itchy and looking like other common skin ...
The CAR-T cell therapy Carvykti has been shown to be effective among patients outside the confines of a clinical trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback